Vortioxetine improves gastrointestinal motility and reduces intestinal inflammation in a cuprizone-induced multiple sclerosis model in mice. Annals of Medical Research, [S. l.], v. 33, n. 5, p. 192–198, 2026. Disponível em: http://www.annalsmedres.org/index.php/aomr/article/view/4909. Acesso em: 1 jun. 2026.